Healthcare -
Biotechnology - NASDAQ - US
$ 4.07
-2.63 %
$ 141 M
Market Cap
-4.33
P/E
GNLX - TOTAL CURRENT ASSETS
Total Current Assets GNLX - Genelux Corporation
24.2 M
LAST VALUE
103.89%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR